NO970252L - Blanding for nasal administrering av et medikament - Google Patents

Blanding for nasal administrering av et medikament

Info

Publication number
NO970252L
NO970252L NO970252A NO970252A NO970252L NO 970252 L NO970252 L NO 970252L NO 970252 A NO970252 A NO 970252A NO 970252 A NO970252 A NO 970252A NO 970252 L NO970252 L NO 970252L
Authority
NO
Norway
Prior art keywords
drug
mixture
nasal administration
nasal
administration
Prior art date
Application number
NO970252A
Other languages
English (en)
Norwegian (no)
Other versions
NO970252D0 (no
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
Danbiosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO970252D0 publication Critical patent/NO970252D0/no
Publication of NO970252L publication Critical patent/NO970252L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Tires In General (AREA)
  • Tyre Moulding (AREA)
NO970252A 1994-07-26 1997-01-21 Blanding for nasal administrering av et medikament NO970252L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414966A GB9414966D0 (en) 1994-07-26 1994-07-26 Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en) 1994-07-26 1995-07-24 Drug delivery composition for the nasal administration of antiviral agents

Publications (2)

Publication Number Publication Date
NO970252D0 NO970252D0 (no) 1997-01-21
NO970252L true NO970252L (no) 1997-01-21

Family

ID=10758832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970252A NO970252L (no) 1994-07-26 1997-01-21 Blanding for nasal administrering av et medikament

Country Status (7)

Country Link
EP (1) EP0773791A1 (fi)
JP (1) JPH10506376A (fi)
CA (1) CA2195639A1 (fi)
FI (1) FI970331A0 (fi)
GB (2) GB9414966D0 (fi)
NO (1) NO970252L (fi)
WO (1) WO1996003142A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5879712A (en) * 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
ATE242001T1 (de) * 1996-03-06 2003-06-15 Boehringer Ingelheim Pharma Pulverförmiges arzneimittel enthaltend interzelluläres adhäsionsmolekül
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
CA2296620A1 (en) * 1997-07-18 1999-01-28 Kris P. Antonsen Methods of removing residual solvent from nasal drug delivery compositions
CA2308291A1 (en) * 1997-10-31 1999-05-14 Thierry Nivaggioli Controlled release compositions comprising gellan gum gels
DK1035833T3 (da) * 1997-12-02 2006-01-09 Archimedes Dev Ltd Sammensætning til nasal indgivelse
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
RU2185822C2 (ru) * 2000-08-01 2002-07-27 Общество с ограниченной ответственностью "Фармаген" Препарат для лечения и профилактики вирусных заболеваний
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
DE102008007759B4 (de) 2007-12-04 2009-09-24 Atlantichem Gmbh Mittel zum Verhindern von Verfärbungen beim Waschen von Textilien

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
ES2064327T3 (es) * 1987-11-02 1995-02-01 Baylor College Medicine Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
DE68929096T2 (de) * 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
SE8804164A0 (sv) * 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
AU2763692A (en) * 1991-10-02 1993-05-03 Boehringer Ingelheim Pharmaceuticals, Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
JPH06510208A (ja) * 1992-06-22 1994-11-17 マイルス・インコーポレーテツド 多量体形態のヒトライノウイルスレセプタ蛋白質
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
GB2305606B (en) 1998-08-05
FI970331L (fi) 1997-01-27
GB9414966D0 (en) 1994-09-14
AU707462B2 (en) 1999-07-08
AU2988695A (en) 1996-02-22
FI970331A7 (fi) 1997-01-27
GB9700817D0 (en) 1997-03-05
NO970252D0 (no) 1997-01-21
EP0773791A1 (en) 1997-05-21
GB2305606A (en) 1997-04-16
FI970331A0 (fi) 1997-01-27
WO1996003142A1 (en) 1996-02-08
CA2195639A1 (en) 1996-02-08
JPH10506376A (ja) 1998-06-23

Similar Documents

Publication Publication Date Title
NO975931D0 (no) Blanding for administrering av medikament
NO970252L (no) Blanding for nasal administrering av et medikament
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
NO20001219D0 (no) Blanding for medikament-administrasjon
US5506203C1 (en) Systemic administration of a therapeutic preparation
GB2303064B (en) Medicament for nasal administration
KR950700754A (ko) 신규의 약물(novel medicament)
NO953549L (no) Infusjonssett for en intermitterende eller kontinuerlig avlevering av en terapeutisk substans
IS4566A (is) Lyfjablanda til að gefa í gegnum húð
NO972798D0 (no) Intravaginale medikamentleveringsanordninger for administrasjon av 17<beta>-östradiolforlöpere
MX9101175A (es) Composicion farmaceutica para administracion nasal
NO950238D0 (no) Blanding for tilförsel av legemiddel til lymfesystemet
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
FI954007L (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
NO981537L (no) FremgangsmÕte for fremstilling av antimalariamedikamenter
NO20000811D0 (no) Fremgangsmåte for valg av medicament
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
GB9304549D0 (en) Apparatus for administration of drugs
SE9400372D0 (sv) Systemic administration of a therapeutic preparation
NO902022D0 (no) Nasal administrering av benzodiazepin-sovemidler.
GB9418414D0 (en) Long-term administration of drugs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application